146 related articles for article (PubMed ID: 26383540)
1. Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III.
Bednarczyk D; Boiselle C
Xenobiotica; 2016; 46(5):457-66. PubMed ID: 26383540
[TBL] [Abstract][Full Text] [Related]
2. Pre-incubation with OATP1B1 and OATP1B3 inhibitors potentiates inhibitory effects in physiologically relevant sandwich-cultured primary human hepatocytes.
Farasyn T; Pahwa S; Xu C; Yue W
Eur J Pharm Sci; 2021 Oct; 165():105951. PubMed ID: 34311070
[TBL] [Abstract][Full Text] [Related]
3. Rifampin- and Silymarin-Mediated Pharmacokinetic Interactions of Exogenous and Endogenous Substrates in a Transgenic OATP1B Mouse Model.
Bechtold BJ; Lynch KD; Oyanna VO; Call MR; Graf TN; Oberlies NH; Clarke JD
Mol Pharm; 2024 May; 21(5):2284-2297. PubMed ID: 38529622
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport.
Pahwa S; Alam K; Crowe A; Farasyn T; Neuhoff S; Hatley O; Ding K; Yue W
J Pharm Sci; 2017 Aug; 106(8):2123-2135. PubMed ID: 28373111
[TBL] [Abstract][Full Text] [Related]
5. Human Organic Anion Transporting Polypeptides 1B1, 1B3, and 2B1 Are Involved in the Hepatic Uptake of Phenolsulfonphthalein.
Wang Z; Li Y; Peng T; Su Y; Luo X; Han W; Zhang H; Ruan J; Gui C
ACS Omega; 2021 Dec; 6(51):35844-35851. PubMed ID: 34984313
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice.
Bechtold BJ; Lynch KD; Oyanna VO; Call MR; White LA; Graf TN; Oberlies NH; Clarke JD
Drug Metab Dispos; 2024 Apr; 52(5):355-367. PubMed ID: 38485280
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Organic Anion Transporting Polypeptide (OATP) 1B1 Transport Function by Lysosomotropic Drug Chloroquine: Implication in OATP-Mediated Drug-Drug Interactions.
Alam K; Pahwa S; Wang X; Zhang P; Ding K; Abuznait AH; Li L; Yue W
Mol Pharm; 2016 Mar; 13(3):839-51. PubMed ID: 26750564
[TBL] [Abstract][Full Text] [Related]
8. Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice.
Loos NHC; Ferreira Martins ML; Rijmers J; de Jong D; Lebre MC; Tibben M; Beijnen JH; Schinkel AH
Mol Pharm; 2024 Apr; 21(4):1952-1964. PubMed ID: 38423793
[TBL] [Abstract][Full Text] [Related]
9. Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interaction Potential of Vemurafenib Using R-Value and Physiologically-Based Pharmacokinetic Models.
Kayesh R; Farasyn T; Crowe A; Liu Q; Pahwa S; Alam K; Neuhoff S; Hatley O; Ding K; Yue W
J Pharm Sci; 2021 Jan; 110(1):314-324. PubMed ID: 32590030
[TBL] [Abstract][Full Text] [Related]
10. Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic.
Yadav AS; Stevison F; Kosaka M; Wong S; Kenny JR; Amory JK; Isoherranen N
Drug Metab Dispos; 2022 Jul; 50(7):1042-1052. PubMed ID: 35545255
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human drug transporter activities by succinate dehydrogenase inhibitors.
Kerhoas M; Le Vée M; Carteret J; Jouan E; Tastet V; Bruyère A; Huc L; Fardel O
Chemosphere; 2024 Jun; 358():142122. PubMed ID: 38663675
[TBL] [Abstract][Full Text] [Related]
12. Utilization of OATP1B Biomarker Coproporphyrin-I to Guide Drug-Drug Interaction Risk Assessment: Evaluation by the Pharmaceutical Industry.
Kikuchi R; Chothe PP; Chu X; Huth F; Ishida K; Ishiguro N; Jiang R; Shen H; Stahl SH; Varma MVS; Willemin ME; Morse BL
Clin Pharmacol Ther; 2023 Dec; 114(6):1170-1183. PubMed ID: 37750401
[TBL] [Abstract][Full Text] [Related]
13. Various effects of repeated rifampin dosing on coproporphyrin levels in humans.
Kinzi J; Grube M; Brecht K; Seibert I; Siegmund W; Meyer Zu Schwabedissen HE
Clin Transl Sci; 2023 Nov; 16(11):2289-2298. PubMed ID: 37705216
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Determinants of Daprodustat Drug-Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B-CYP2C8 Interplay.
Bi YA; Jordan S; King-Ahmad A; West MA; Varma MVS
Clin Pharmacol Ther; 2024 Jun; 115(6):1336-1345. PubMed ID: 38404228
[TBL] [Abstract][Full Text] [Related]
15. Cryo-EM structures of human organic anion transporting polypeptide OATP1B1.
Shan Z; Yang X; Liu H; Yuan Y; Xiao Y; Nan J; Zhang W; Song W; Wang J; Wei F; Zhang Y
Cell Res; 2023 Dec; 33(12):940-951. PubMed ID: 37674011
[TBL] [Abstract][Full Text] [Related]
16. Development of a Suite of Gadolinium-Free OATP1-Targeted Paramagnetic Probes for Liver MRI.
McRae SW; Cleary M; DeRoche D; Martinez FM; Xia Y; Caravan P; Gale EM; Ronald JA; Scholl TJ
J Med Chem; 2023 May; 66(10):6567-6576. PubMed ID: 37159947
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic account of distinct change in organic anion transporting polypeptide 1B (OATP1B) substrate pharmacokinetics during OATP1B-mediated drug-drug interactions using physiologically-based pharmacokinetic modeling.
Hegde PV; Morse BL
Drug Metab Dispos; 2024 May; ():. PubMed ID: 38740464
[TBL] [Abstract][Full Text] [Related]
18. The 2-aminoethyl diphenylborinate-based fluorescent method identifies quercetin and luteolin metabolites as substrates of Organic anion transporting polypeptides, OATP1B1 and OATP2B1.
Kaci H; Bakos É; Needs PW; Kroon PA; Valentová K; Poór M; Özvegy-Laczka C
Eur J Pharm Sci; 2024 May; 196():106740. PubMed ID: 38437885
[TBL] [Abstract][Full Text] [Related]
19. Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics.
Walker AL; Lancaster CS; Finkelstein D; Ware RE; Sparreboom A
Am J Physiol Cell Physiol; 2013 Dec; 305(12):C1223-9. PubMed ID: 23986199
[TBL] [Abstract][Full Text] [Related]
20. Darolutamide does not interfere with OATP-mediated uptake of docetaxel.
Buck SAJ; Talebi Z; Drabison T; Jin Y; Gibson AA; Hu P; de Bruijn P; de Ridder CMA; Stuurman D; Hu S; van Weerden WM; Koolen SLW; de Wit R; Sparreboom A; Mathijssen RHJ; Eisenmann ED
Int J Cancer; 2024 Jul; 155(2):314-323. PubMed ID: 38491867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
